28-Mar-2024
TipRanks ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Sending a Bullish Signal
TipRanks (Wed, 27-Mar 6:25 AM ET)
TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Sending a Bullish Signal
TipRanks (Wed, 27-Mar 6:25 AM ET)
PRNewswire (Tue, 12-Mar 6:00 AM ET)
IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events
PRNewswire (Mon, 4-Mar 6:00 AM ET)
PRNewswire (Tue, 20-Feb 6:00 AM ET)
IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events
PRNewswire (Thu, 1-Feb 6:00 AM ET)
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PRNewswire (Fri, 26-Jan 6:00 AM ET)
PRNewswire (Sun, 7-Jan 9:00 AM ET)
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
Ideaya Biosciences trades on the NASDAQ stock market under the symbol IDYA.
As of March 28, 2024, IDYA stock price climbed to $43.88 with 704,486 million shares trading.
IDYA has a beta of 0.77, meaning it tends to be less sensitive to market movements. IDYA has a correlation of 0.04 to the broad based SPY ETF.
IDYA has a market cap of $3.27 billion. This is considered a Mid Cap stock.
Last quarter Ideaya Biosciences reported $4 million in Revenue and -$.52 earnings per share. This fell short of revenue expectation by $-5 million and missed earnings estimates by -$.05.
In the last 3 years, IDYA stock traded as high as $47.74 and as low as $8.14.
The top ETF exchange traded funds that IDYA belongs to (by Net Assets): VTI, XBI, IWM, VXF, IBB.
IDYA has outperformed the market in the last year with a return of +219.4%, while the SPY ETF gained +33.6%. In the last 3 month period, IDYA beat the market returning +24.2%, while SPY returned +10.1%. However, in the most recent 2 weeks IDYA has underperformed the stock market by returning -4.0%, while SPY returned +1.7%.
IDYA support price is $42.06 and resistance is $44.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IDYA stock will trade within this expected range on the day.